Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
IBI355 is an Fc-silent, third-generation anti-CD40L antibody that is expected to...
Company introduces a non-surgical hair restoration treatment based on exosome t...
Rosof assumes regional leadership role and will also oversee the ASEAN cluster ...
Heena Santry, MD, MS, MBA ,FACS, EDAC, recently joined the Columbus, Ohio, offic...
The American Hospital Association (AHA) recently announced the appointment of St...
Hitoe AdVantage by Toli features a refined granular visual designed for the most...
SBT-77-7101 is described as an autologous CAR-Treg cell therapy currently in Pha...
The agreement grants Novartis access to Chai Discovery’s latest AI models, inclu...
RPG Life Sciences (RPG LS) has partnered with Archerchem Healthcare to launch N...
Emcure Pharmaceuticals announced the consolidation of its shareholding in bioph...
Animal health has become one of the defining priorities for agriculture across ...
OneSource Specialty Pharma, a multi-modality specialty pharma CDMO, and Formyco...
How has the launch of GLP-1 medication disrupted weight loss/obesity care model...
Leiutis Pharmaceuticals LLP has announced that the Central Drugs Standard Contr...
Company to launch once-weekly injectable for adults with type 2 diabetes in the...
Cleveland Clinic is moving forward on two major capital initiatives that undersc...